NCT05421715Completed
Remote Digital Care Effects in Adolescents With Type 1 Diabetes
Preliminary Study for the Evaluation of Teleduc-diab Additional Remote Digitalcare Effects in Adolescents With Poorly Controled Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
Pilot study to evaluate effects of an experimental additional remote digital care (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring platform and educative app
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 13 Jun 2022
- Start date
- 11 Apr 2023
- Primary completion date
- 11 Oct 2024
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Type 1 diabetes
- NCT number
- NCT05421715
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 11 Apr 2023 to the primary completion date, 11 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other pathologies associated with diabetes which, according to the investigator, could interfere with glycemic control or the management of adolescent diabetes (examples: secondary diabetes, cystic fibrosis, Down syndrome; transplants, corticosteroid therapy, etc.)
Who the study is looking for
- Adolescent aged ≥12 and \<18, with primary type 1 diabetes detected for at least 12 months, treated with multi-injection insulin or insulin pump
- Glycated hemoglobin greater than or equal to 8% for more than 3 months
- Use a continuous interstitial glucose recording system (CGM)
- Have at least one parent/guardian with a significant caregiver role in the management of the adolescent's diabetes (as determined by the investigator) participating in the study
- Have digital media compatible with the digital applications of the TELEDUC- DIAB (Mobile phone and computer)
Age in the registry: 12 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital, Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.